1.Association between fasting blood glucose level and difficulty with chewing: the Aichi Workers' Cohort Study.
Mohammad Hassan HAMRAH ; Zean SONG ; Youngjae HONG ; Tahmina AKTER ; Hanson Gabriel NUAMAH ; Natsuko GONDO ; Masaaki MATSUNAGA ; Atsuhiko OTA ; Midori TAKADA ; Rei OTSUKA ; Koji TAMAKOSHI ; Hiroshi YATSUYA
Environmental Health and Preventive Medicine 2025;30():95-95
BACKGROUND:
Difficulty in chewing has been shown to be associated with increased mortality, geriatric syndromes, and poor activities of daily living, indicating the need for intervention. Chewing difficulties are related to tooth loss, periodontitis, dry mouth, and a number of oral health conditions. Diabetes mellitus (DM) is one of the major causes of global burden of diseases, and has been associated with poor oral health. Prospective association between oral health status and the development of diabetes has also been reported. However, relationship between glycemic control and self-reported chewing difficulty remains less explored in working-age populations. The objective of this study is to cross-sectionally explore the association between fasting blood glucose (FBG) and self-reported chewing difficulty in adults working in a Japanese worksite.
METHODS:
Participants from the Aichi Workers' Cohort Study who responded to the 2018 survey were included. Participants were categorized into five FBG groups (<100, 100-109, 110-125, 126-159, and ≥160 mg/dl). Multivariable odds ratios (ORs) and 95% confidence intervals (CIs) for chewing difficulty were estimated using logistic regression adjusted for age, sex, body mass index, smoking and alcohol consumption status, number of teeth, presence of periodontal disease and the number of anti-diabetic medication classes.
RESULTS:
A total of 164 participants (4.2%) reported difficulty with chewing, the prevalence of which tended to increase with increasing FBG level. FBG ≥160 mg/dl was significantly and strongly associated with difficulty with chewing in the final multivariable model (multivariable OR 3.84 [95% CI 1.13-13.0]).
CONCLUSIONS
A relationship between higher FBG levels and difficulty with chewing was observed, independent of potential confounding factors. However, prospective or interventional studies are needed to determine causality.
Humans
;
Male
;
Japan/epidemiology*
;
Female
;
Mastication/physiology*
;
Middle Aged
;
Adult
;
Blood Glucose/analysis*
;
Cross-Sectional Studies
;
Fasting/blood*
;
Cohort Studies
;
Oral Health
;
Prevalence
2.Anti-diabetic effects of benfotiamine on an animal model of type 2 diabetes mellitus.
Kang Min CHUNG ; Wonyoung KANG ; Dong Geon KIM ; Hyun Ju HONG ; Youngjae LEE ; Chang Hoon HAN
Korean Journal of Veterinary Research 2014;54(1):21-26
Although benfotiamine has various beneficial anti-diabetic effects, the detailed mechanisms underlying the impact of this compound on the insulin signaling pathway are still unclear. In the present study, we evaluated the effects of benfotiamine on the hepatic insulin signaling pathway in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, which are a type 2 diabetes mellitus model. OLETF rats treated with benfotiamine showed decreased body weight gain and reduced adipose tissue weight. In addition, blood glucose levels were lower in OLETF rats treated with benfotiamine. Following treatment with benfotiamine, the levels of Akt phosphorylation (S473/T308) in the OLETF groups increased significantly compared to the OLETF control group so that they were almost identical to the levels observed in the control group. Moreover, benfotiamine restored the phosphorylation levels of both glycogen synthase kinase (GSK)-3alpha/beta (S21, S9) and glycogen synthase (GS; S641) in OLETF rats to nearly the same levels observed in the control group. Overall, these results suggest that benfotiamine can potentially attenuate type 2 diabetes mellitus in OLETF rats by restoring insulin sensitivity through upregulation of Akt phosphorylation and activation of two downstream signaling molecules, GSK-3alpha/beta and GS, thereby reducing blood glucose levels through glycogen synthesis.
Adipose Tissue
;
Animals*
;
Blood Glucose
;
Body Weight
;
Diabetes Mellitus, Type 2*
;
Glycogen
;
Glycogen Synthase
;
Glycogen Synthase Kinases
;
Insulin
;
Insulin Resistance
;
Models, Animal*
;
Phosphorylation
;
Rats
;
Rats, Inbred OLETF
;
Up-Regulation
3.Effects of resveratrol on the insulin signaling pathway of obese mice.
Hyun Ju HONG ; Wonyoung KANG ; Dong Geon KIM ; Dae Ho LEE ; Youngjae LEE ; Chang Hoon HAN
Journal of Veterinary Science 2014;15(2):179-185
The present study was conducted to investigate the effects of resveratrol on the insulin signaling pathway in the liver of obese mice. To accomplish this, we administered resveratrol to high fat diet-induced obese mice and examined the levels of protein phosphorylation in the liver using an antibody array. The phosphorylation levels of 10 proteins were decreased in the high fat diet and resveratrol (HFR) fed group relative to the levels in the high fat diet (HF) fed group. In contrast, the phosphorylation levels of more than 20 proteins were increased in the HFR group when compared with the levels of proteins in the HF group. Specifically, the phosphorylation levels of Akt (The308, Tyr326, Ser473) were restored to normal by resveratrol when compared with the levels in the HF group. In addition, the phosphorylation levels of IRS-1 (Ser636/Ser639), PI-3K p85-subunit alpha/gamma(Tyr467/Tyr199), PDK1 (Ser241), GSK-3alpha (S21) and GSK-3 (Ser9), which are involved in the insulin signaling pathway, were decreased in the HF group, whereas the levels were restored to normal in the HFR group. Overall, the results show that resveratrol restores the phosphorylation levels of proteins involved in the insulin signaling pathway, which were decreased by a high fat diet.
Animals
;
Anti-Inflammatory Agents/*pharmacology
;
Fluorescent Antibody Technique
;
Insulin/*physiology
;
Liver/*metabolism
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Mice, Obese
;
Phosphorylation
;
Proteins/metabolism
;
Signal Transduction/*drug effects
;
Stilbenes/*pharmacology
4.Comparative evaluation of the murine immune responses to Salmonella enterica serovars Enteritidis, Gallinarum and Typhimurium infection.
Kiju KIM ; Dooree KIM ; Jisun SUN ; Soyeon PARK ; Youngjae CHO ; Hyun Jeong KO ; Hong Gu JOO ; Tae Wook HAHN
Korean Journal of Veterinary Research 2013;53(2):95-101
The study was carried out to evaluate and compare the immune responses in mice experimentally infected with either wild-type or isogenic mutants of Salmonella enterica serovars Enteritidis (SE), Salmonella Typhimurium (ST) and Gallinarum (SG). The mutant strains were constructed by allelic replacement of some virulence-associated genes in the wild-type strains. Seven-week-old female BALB/c mice were orally or intraperitoneally inoculated by injecting bacterial suspension. To evaluate the immune responses, enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immunospot (ELISPOT) assay were conducted with serum and fecal samples. As a result, the mice group infected orally with the SE mutant strain showed the highest level of specific IgA-secreting splenocytes, compared to the other groups. The peritoneally injected groups showed the greater levels of IgG1 than the orally injected groups, which was in a good agreement with the previous studies. In addition, the mutant infected groups had the similar secretion levels of antibodies with the wild-type infected groups. These results demonstrated that the SE mutant strain elicited humoral immune response as much as wild-type, implying that it can be useful as a delivery vehicle as well as a candidate of a live attenuated vaccine.
Animals
;
Antibodies
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Humans
;
Immunity, Humoral
;
Immunity, Mucosal
;
Immunoglobulin G
;
Mice
;
Salmonella
;
Salmonella enterica
;
Salmonella typhimurium
;
Sprains and Strains

Result Analysis
Print
Save
E-mail